Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers

Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers

US Patent 9623009 · Granted Apr 18, 2017

Estimated economic value: $146,490,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quantitative mapping of MRI relaxation parameters2025
Measurement of blood volume using Fourier-transform based velocity-selective pul2025
Data processing method and apparatus, computer device, and readable storage medi2024
Analyzer and control method thereof, detection system, and storage medium2024
Intraoperative neural monitoring method2024
Apparatus for dismounting and mounting high-voltage line T-connector in hot-line2023
Methods of treating mixed dyslipidemia and hypertriglycertdemia2022
Methods of preventing the occurrence of cardiovascular events2020
Methods of preventing cardiovascular events in residual risk dyslipidemic popula2020
System and method for velocity selective pulses with arbitrary shape using MRI2019
Measurement of blood volume using velocity-selective pulse trains on MRI2019
Active stylus and control circuit thereof2018